RSS

UNVC Univec Conglomerate Inc

Last Post: 9:50 AM
Followers: 228
Posts Today: 1
Views Today: 9873

UNVC Stock Quote & Tools

$0.0014 ▼ -0.0005 (-25.00%) As of Oct 23, 3:11 PM EDT
Last0.0014
$ Chg-0.0005
Open0.0015
High0.0017
Beta0.8504
Year High0.005
Market Cap3.41M
P/B Ratio—
EPS—
Avg Vol (30d)285.3K
Volume1.40M
% Chg-25.00%
Prev Close0.0018
Low0.0014
VWAP0.00150
Year Low0.001
Total Shares2.52B
Shares Out2.52B
Float2.52B
ExchangeOTCID
Healthcare Healthcare Providers & Services

UNVC Stock Message Board Discussion

  1. armyseal
  2. toodles
  3. All Good
  4. All Good

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 98

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 0

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading

Top 5 Most Recently Viewed Articles

Stocks Rebound in Volatile Trading After Major Sell-off

Updated Category Markets Views 525

Global Stocks See Slight Uptick Amid Market Volatility Tuesday saw global stocks climb, yet trading was erratic. Following Monday's forceful selloff, investors remained wary. Officials of central banks aimed at reassuring the markets. Some respite came from Tokyo overnight's 10% rebound in Nikkei. Investor mood was still wary, though. U.S. stock futures displayed mixed...

Continue Reading
Projecting the Growth of the Femtech Market Through 2031

Updated Category News Views 77

The Femtech market stood at an impressive USD 33.92 billion back in 2023, setting the stage for its remarkable leap to a projected value of USD 113.53 billion by 2031. That’s a compound annual growth rate (CAGR) of about 16.3%. So, what's fueling this explosion? For starters, it's all about the rising awareness surrounding women's health issues—a topic that finally...

Continue Reading
Vestis Corporation Class Action Lawsuit: Key Details to Know

Updated Category News Views 494

Class Action Lawsuit Against Vestis Corporation Pomerantz LLP is drawing attention to a class action lawsuit filed against Vestis Corporation (NYSE: VSTS) concerning allegations of securities fraud. Investors who have incurred losses due to their investment in Vestis are encouraged to take action. Deadline for Investors Investors have until August 8, 2025, to request the...

Continue Reading
Associated Banc-Corp Sets Public Offering for Growth Funding

Updated Category News Views 215

Associated Banc-Corp Announces Stock Offering Associated Banc-Corp (NYSE: ASB) has recently made headlines with its announcement regarding a public offering of its common stock. The company is set to offer 12 million shares, each with a par value of $0.01, at a price of $25.00 per share. This means the total gross proceeds from this offering are expected to reach an...

Continue Reading
Olaplex Holdings Inc. to Engage at Canaccord Genuity Growth Conference

Updated Category News Views 138

Olaplex Holdings Inc. to Engage at Canaccord Genuity Growth Conference Olaplex Holdings, Inc. (NASDAQ: OLPX) has recently confirmed its engagement in the Canaccord Genuity 45th Annual Growth Conference. This prestigious event is set to take place soon, where the company will have a platform to showcase its commitment to innovation in the beauty and hair care industry....

Continue Reading